Nukleinsyremolekyl for optimalisert ekspresjon av HPV52-L1 i gjær, vektor og vertscelle, samt fremgangsmåte for fremstilling av HPV52L1 viruslignende partikler, og deres anvendelse ved fremstilling av en vaksine for behandling eller forebygging av HPV-assosiert cervikal kreft
Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the n...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | nor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Schultz, Loren D Jansen, Kathrin Ute Bryan, Janine T Brownlow, Michelle K |
| description | Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO338055BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO338055BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO338055BB13</originalsourceid><addsrcrecordid>eNqNj71OAzEMgMvAgICV2Q_Qkyink5iLQB1QYUCslXvnC25yyclOI90DwYv0xUgKgoGFyZZ_vs8-O7la760j9joJDcGRnRz0QSCMkQd0rCQRyOoopLvgAROsnl-bm-pxAQxmd_iQOSSyseyYnEnUlpyjOSgOEfqMNeiNDof3SEd0KWlk59ibH17GJZa9OjaefEcwokTOp2V85naU_YA-lZ5TyqLuD4g8JLTK_suzpTf03bFZDpJSpO1kzK-3QtWgXH5sSRJbdGCF-ngxO-0xey6_4_kMHu5f7lYVjWFDOmJLnuJm_VTXt9dNs1wu6n-MfAJSnoD7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Nukleinsyremolekyl for optimalisert ekspresjon av HPV52-L1 i gjær, vektor og vertscelle, samt fremgangsmåte for fremstilling av HPV52L1 viruslignende partikler, og deres anvendelse ved fremstilling av en vaksine for behandling eller forebygging av HPV-assosiert cervikal kreft</title><source>esp@cenet</source><creator>Schultz, Loren D ; Jansen, Kathrin Ute ; Bryan, Janine T ; Brownlow, Michelle K</creator><creatorcontrib>Schultz, Loren D ; Jansen, Kathrin Ute ; Bryan, Janine T ; Brownlow, Michelle K</creatorcontrib><description>Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections.</description><language>nor</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160725&DB=EPODOC&CC=NO&NR=338055B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160725&DB=EPODOC&CC=NO&NR=338055B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Schultz, Loren D</creatorcontrib><creatorcontrib>Jansen, Kathrin Ute</creatorcontrib><creatorcontrib>Bryan, Janine T</creatorcontrib><creatorcontrib>Brownlow, Michelle K</creatorcontrib><title>Nukleinsyremolekyl for optimalisert ekspresjon av HPV52-L1 i gjær, vektor og vertscelle, samt fremgangsmåte for fremstilling av HPV52L1 viruslignende partikler, og deres anvendelse ved fremstilling av en vaksine for behandling eller forebygging av HPV-assosiert cervikal kreft</title><description>Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNj71OAzEMgMvAgICV2Q_Qkyink5iLQB1QYUCslXvnC25yyclOI90DwYv0xUgKgoGFyZZ_vs8-O7la760j9joJDcGRnRz0QSCMkQd0rCQRyOoopLvgAROsnl-bm-pxAQxmd_iQOSSyseyYnEnUlpyjOSgOEfqMNeiNDof3SEd0KWlk59ibH17GJZa9OjaefEcwokTOp2V85naU_YA-lZ5TyqLuD4g8JLTK_suzpTf03bFZDpJSpO1kzK-3QtWgXH5sSRJbdGCF-ngxO-0xey6_4_kMHu5f7lYVjWFDOmJLnuJm_VTXt9dNs1wu6n-MfAJSnoD7</recordid><startdate>20160725</startdate><enddate>20160725</enddate><creator>Schultz, Loren D</creator><creator>Jansen, Kathrin Ute</creator><creator>Bryan, Janine T</creator><creator>Brownlow, Michelle K</creator><scope>EVB</scope></search><sort><creationdate>20160725</creationdate><title>Nukleinsyremolekyl for optimalisert ekspresjon av HPV52-L1 i gjær, vektor og vertscelle, samt fremgangsmåte for fremstilling av HPV52L1 viruslignende partikler, og deres anvendelse ved fremstilling av en vaksine for behandling eller forebygging av HPV-assosiert cervikal kreft</title><author>Schultz, Loren D ; Jansen, Kathrin Ute ; Bryan, Janine T ; Brownlow, Michelle K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO338055BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2016</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>Schultz, Loren D</creatorcontrib><creatorcontrib>Jansen, Kathrin Ute</creatorcontrib><creatorcontrib>Bryan, Janine T</creatorcontrib><creatorcontrib>Brownlow, Michelle K</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Schultz, Loren D</au><au>Jansen, Kathrin Ute</au><au>Bryan, Janine T</au><au>Brownlow, Michelle K</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Nukleinsyremolekyl for optimalisert ekspresjon av HPV52-L1 i gjær, vektor og vertscelle, samt fremgangsmåte for fremstilling av HPV52L1 viruslignende partikler, og deres anvendelse ved fremstilling av en vaksine for behandling eller forebygging av HPV-assosiert cervikal kreft</title><date>2016-07-25</date><risdate>2016</risdate><abstract>Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | nor |
| recordid | cdi_epo_espacenet_NO338055BB1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | Nukleinsyremolekyl for optimalisert ekspresjon av HPV52-L1 i gjær, vektor og vertscelle, samt fremgangsmåte for fremstilling av HPV52L1 viruslignende partikler, og deres anvendelse ved fremstilling av en vaksine for behandling eller forebygging av HPV-assosiert cervikal kreft |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T13%3A53%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Schultz,%20Loren%20D&rft.date=2016-07-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO338055BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |